Skip Navigation
Skip Ribbon Commands
Skip to main content
NIAID > Labs & Scientific Resources > Resources for Researchers > DMID Resources for Researchers > Therapeutic Development Services
Skip Website Tools Skip Stay Connected
Stay Connected
Stay connected on Facebook
Stay connected on Twitter
Stay connected on flickr
Stay connected on YouTube
Social media privacy policy and disclaimers.

Contact Info

Beth Spinelli (Interventional Agents)
Project Officer, Drug Development Section
Office of Biodefense Research Affairs
Email: spinellb@niaid.nih.gov

Raymond Harris (Biopharmaceutical Products)
Program Officer
Office of Biodefense Research Affairs
Email: harrisr2@niaid.nih.gov

Resources for Researchers

Therapeutic Development Services

The Therapeutic Development Services program offers a collection of preclinical services to support the development of products intended for use in the cure, mitigation, diagnosis or treatment of disease caused by a pathogen or certain toxins, including:

  • Interventional Agents—therapeutics and new in vivo diagnostics for infectious disease-causing pathogens and/or toxins, such as imaging and skin test reagents.
  • Biopharmaceutical Products—therapeutics that are derived from biotechnology processes, such as monoclonal antibodies and derivatives of monoclonal antibodies; recombinant proteins; peptides; nucleic acid based vectors (siRNA, plasmids); and live, modified-live and/or attenuated entities.

Last Updated November 23, 2011